Dow Jones
33.717,09 -260,99 (-0,77%) Nasdaq
11.393,81 -227,90 (-1,96%) Nikkei 225
27.433,40 +50,84 (+0,19%) EUR/USD
1,0853 -0,0021 (-0,20%) BTC-EUR
20.934,15 -1.145,08 (-5,19%) CMC Crypto 200
514,97 -22,91 (-4,26%)
Grifols, S.A. (GRF.MC)
| Chiusura precedente | 12,52 |
| Aperto | 12,47 |
| Denaro | 12,14 x 0 |
| Lettera | 12,20 x 0 |
| Min-Max giorno | 12,14 - 12,50 |
| Intervallo di 52 settimane | 7,82 - 20,28 |
| Volume | |
| Media Volume | 1.692.339 |
| Capitalizzazione | 7,273B |
| Beta (5 anni mensile) | 0,42 |
| Rapporto PE (ttm) | 121,95 |
| EPS (ttm) | 0,10 |
| Prossima data utili | 28 feb 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | 03 giu 2021 |
| Stima target 1A | 18,71 |
- GlobeNewswire
GigaGen Awarded Contract by U.S. Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens
SOUTH SAN FRANCISCO, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immune deficiencies, infectious diseases and checkpoint resistant cancers, and a subsidiary of Grifols, announced today it has entered into a contract with the U.S. Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to demonstrate the utility of its first-in-class recombi
- GlobeNewswire
GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform to Improve Antibody Drug Discovery and Development
SOUTH SAN FRANCISCO, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immune deficiencies, infectious diseases and checkpoint resistant cancers, and a subsidiary of Grifols, announced today the publication of a research article titled, “Predicting antibody binders and generating synthetic antibodies using deep learning,” in the peer-reviewed journal mAbs. The article demonstrates the potential of GigaGen’s machine learning
- GlobeNewswire
Deutsche Bank’s Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewing
NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Deutsche Bank today announced that the presentations from the May 10th and 11th Depositary Receipts Virtual Investor Conference (“dbVIC”) are now available for on-demand viewing. The event featured presentations from international companies with American Depositary Receipt (ADR) programs in the US. Representatives from participating companies based in China, Hong Kong, Germany, Portugal, South Africa, Spain and the UK presented their equity stories and
